Global Viral Inactivation Market Size, Status and Forecast 2021-2027
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Inactivation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Kits and Reagents
1.2.3 Services
1.2.4 Viral Inactivation Systems and Accessories
1.3 Market by Application
1.3.1 Global Viral Inactivation Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Blood and Blood Products
1.3.3 Cellular and Gene Therapy Products
1.3.4 Stem Cell Products
1.3.5 Tissue and Tissue Products
1.3.6 Vaccines and Therapeutics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Viral Inactivation Market Perspective (2016-2027)
2.2 Viral Inactivation Growth Trends by Regions
2.2.1 Viral Inactivation Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Viral Inactivation Historic Market Share by Regions (2016-2021)
2.2.3 Viral Inactivation Forecasted Market Size by Regions (2022-2027)
2.3 Viral Inactivation Industry Dynamic
2.3.1 Viral Inactivation Market Trends
2.3.2 Viral Inactivation Market Drivers
2.3.3 Viral Inactivation Market Challenges
2.3.4 Viral Inactivation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Inactivation Players by Revenue
3.1.1 Global Top Viral Inactivation Players by Revenue (2016-2021)
3.1.2 Global Viral Inactivation Revenue Market Share by Players (2016-2021)
3.2 Global Viral Inactivation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Viral Inactivation Revenue
3.4 Global Viral Inactivation Market Concentration Ratio
3.4.1 Global Viral Inactivation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Inactivation Revenue in 2020
3.5 Viral Inactivation Key Players Head office and Area Served
3.6 Key Players Viral Inactivation Product Solution and Service
3.7 Date of Enter into Viral Inactivation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Inactivation Breakdown Data by Type
4.1 Global Viral Inactivation Historic Market Size by Type (2016-2021)
4.2 Global Viral Inactivation Forecasted Market Size by Type (2022-2027)
5 Viral Inactivation Breakdown Data by Application
5.1 Global Viral Inactivation Historic Market Size by Application (2016-2021)
5.2 Global Viral Inactivation Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Viral Inactivation Market Size (2016-2027)
6.2 North America Viral Inactivation Market Size by Type
6.2.1 North America Viral Inactivation Market Size by Type (2016-2021)
6.2.2 North America Viral Inactivation Market Size by Type (2022-2027)
6.2.3 North America Viral Inactivation Market Size by Type (2016-2027)
6.3 North America Viral Inactivation Market Size by Application
6.3.1 North America Viral Inactivation Market Size by Application (2016-2021)
6.3.2 North America Viral Inactivation Market Size by Application (2022-2027)
6.3.3 North America Viral Inactivation Market Size by Application (2016-2027)
6.4 North America Viral Inactivation Market Size by Country
6.4.1 North America Viral Inactivation Market Size by Country (2016-2021)
6.4.2 North America Viral Inactivation Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Viral Inactivation Market Size (2016-2027)
7.2 Europe Viral Inactivation Market Size by Type
7.2.1 Europe Viral Inactivation Market Size by Type (2016-2021)
7.2.2 Europe Viral Inactivation Market Size by Type (2022-2027)
7.2.3 Europe Viral Inactivation Market Size by Type (2016-2027)
7.3 Europe Viral Inactivation Market Size by Application
7.3.1 Europe Viral Inactivation Market Size by Application (2016-2021)
7.3.2 Europe Viral Inactivation Market Size by Application (2022-2027)
7.3.3 Europe Viral Inactivation Market Size by Application (2016-2027)
7.4 Europe Viral Inactivation Market Size by Country
7.4.1 Europe Viral Inactivation Market Size by Country (2016-2021)
7.4.2 Europe Viral Inactivation Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Viral Inactivation Market Size (2016-2027)
8.2 Asia-Pacific Viral Inactivation Market Size by Type
8.2.1 Asia-Pacific Viral Inactivation Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Viral Inactivation Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Viral Inactivation Market Size by Type (2016-2027)
8.3 Asia-Pacific Viral Inactivation Market Size by Application
8.3.1 Asia-Pacific Viral Inactivation Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Viral Inactivation Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Viral Inactivation Market Size by Application (2016-2027)
8.4 Asia-Pacific Viral Inactivation Market Size by Region
8.4.1 Asia-Pacific Viral Inactivation Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Viral Inactivation Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Viral Inactivation Market Size (2016-2027)
9.2 Latin America Viral Inactivation Market Size by Type
9.2.1 Latin America Viral Inactivation Market Size by Type (2016-2021)
9.2.2 Latin America Viral Inactivation Market Size by Type (2022-2027)
9.2.3 Latin America Viral Inactivation Market Size by Type (2016-2027)
9.3 Latin America Viral Inactivation Market Size by Application
9.3.1 Latin America Viral Inactivation Market Size by Application (2016-2021)
9.3.2 Latin America Viral Inactivation Market Size by Application (2022-2027)
9.3.3 Latin America Viral Inactivation Market Size by Application (2016-2027)
9.4 Latin America Viral Inactivation Market Size by Country
9.4.1 Latin America Viral Inactivation Market Size by Country (2016-2021)
9.4.2 Latin America Viral Inactivation Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Inactivation Market Size (2016-2027)
10.2 Middle East & Africa Viral Inactivation Market Size by Type
10.2.1 Middle East & Africa Viral Inactivation Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Viral Inactivation Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Viral Inactivation Market Size by Type (2016-2027)
10.3 Middle East & Africa Viral Inactivation Market Size by Application
10.3.1 Middle East & Africa Viral Inactivation Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Viral Inactivation Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Viral Inactivation Market Size by Application (2016-2027)
10.4 Middle East & Africa Viral Inactivation Market Size by Country
10.4.1 Middle East & Africa Viral Inactivation Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Viral Inactivation Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Details
11.1.2 Danaher Business Overview
11.1.3 Danaher Viral Inactivation Introduction
11.1.4 Danaher Revenue in Viral Inactivation Business (2016-2021)
11.1.5 Danaher Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Viral Inactivation Introduction
11.2.4 Merck Revenue in Viral Inactivation Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Parker Hannifin
11.3.1 Parker Hannifin Company Details
11.3.2 Parker Hannifin Business Overview
11.3.3 Parker Hannifin Viral Inactivation Introduction
11.3.4 Parker Hannifin Revenue in Viral Inactivation Business (2016-2021)
11.3.5 Parker Hannifin Recent Development
11.4 Sartorius
11.4.1 Sartorius Company Details
11.4.2 Sartorius Business Overview
11.4.3 Sartorius Viral Inactivation Introduction
11.4.4 Sartorius Revenue in Viral Inactivation Business (2016-2021)
11.4.5 Sartorius Recent Development
11.5 SGS
11.5.1 SGS Company Details
11.5.2 SGS Business Overview
11.5.3 SGS Viral Inactivation Introduction
11.5.4 SGS Revenue in Viral Inactivation Business (2016-2021)
11.5.5 SGS Recent Development
11.6 Charles River Laboratories International
11.6.1 Charles River Laboratories International Company Details
11.6.2 Charles River Laboratories International Business Overview
11.6.3 Charles River Laboratories International Viral Inactivation Introduction
11.6.4 Charles River Laboratories International Revenue in Viral Inactivation Business (2016-2021)
11.6.5 Charles River Laboratories International Recent Development
11.7 Clean Cells
11.7.1 Clean Cells Company Details
11.7.2 Clean Cells Business Overview
11.7.3 Clean Cells Viral Inactivation Introduction
11.7.4 Clean Cells Revenue in Viral Inactivation Business (2016-2021)
11.7.5 Clean Cells Recent Development
11.8 Rad Source Technologies
11.8.1 Rad Source Technologies Company Details
11.8.2 Rad Source Technologies Business Overview
11.8.3 Rad Source Technologies Viral Inactivation Introduction
11.8.4 Rad Source Technologies Revenue in Viral Inactivation Business (2016-2021)
11.8.5 Rad Source Technologies Recent Development
11.9 Texcell
11.9.1 Texcell Company Details
11.9.2 Texcell Business Overview
11.9.3 Texcell Viral Inactivation Introduction
11.9.4 Texcell Revenue in Viral Inactivation Business (2016-2021)
11.9.5 Texcell Recent Development
11.10 Viral Inactivated Plasma Systems
11.10.1 Viral Inactivated Plasma Systems Company Details
11.10.2 Viral Inactivated Plasma Systems Business Overview
11.10.3 Viral Inactivated Plasma Systems Viral Inactivation Introduction
11.10.4 Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2016-2021)
11.10.5 Viral Inactivated Plasma Systems Recent Development
11.11 Wuxi Pharmatech (Cayman)
11.11.1 Wuxi Pharmatech (Cayman) Company Details
11.11.2 Wuxi Pharmatech (Cayman) Business Overview
11.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Introduction
11.11.4 Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2016-2021)
11.11.5 Wuxi Pharmatech (Cayman) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Viral Inactivation Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Kits and Reagents
Table 3. Key Players of Services
Table 4. Key Players of Viral Inactivation Systems and Accessories
Table 5. Global Viral Inactivation Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Viral Inactivation Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Viral Inactivation Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Viral Inactivation Market Share by Regions (2016-2021)
Table 9. Global Viral Inactivation Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Viral Inactivation Market Share by Regions (2022-2027)
Table 11. Viral Inactivation Market Trends
Table 12. Viral Inactivation Market Drivers
Table 13. Viral Inactivation Market Challenges
Table 14. Viral Inactivation Market Restraints
Table 15. Global Viral Inactivation Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Viral Inactivation Market Share by Players (2016-2021)
Table 17. Global Top Viral Inactivation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Inactivation as of 2020)
Table 18. Ranking of Global Top Viral Inactivation Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Viral Inactivation Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Viral Inactivation Product Solution and Service
Table 22. Date of Enter into Viral Inactivation Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Viral Inactivation Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Viral Inactivation Revenue Market Share by Type (2016-2021)
Table 26. Global Viral Inactivation Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Viral Inactivation Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Viral Inactivation Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Viral Inactivation Revenue Market Share by Application (2016-2021)
Table 30. Global Viral Inactivation Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Viral Inactivation Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Viral Inactivation Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Viral Inactivation Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Viral Inactivation Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Viral Inactivation Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Viral Inactivation Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Viral Inactivation Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Viral Inactivation Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Viral Inactivation Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Viral Inactivation Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Viral Inactivation Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Viral Inactivation Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Viral Inactivation Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Viral Inactivation Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Viral Inactivation Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Viral Inactivation Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Viral Inactivation Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Viral Inactivation Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Viral Inactivation Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Viral Inactivation Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Viral Inactivation Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Viral Inactivation Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Viral Inactivation Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Viral Inactivation Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Viral Inactivation Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Viral Inactivation Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Viral Inactivation Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Viral Inactivation Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Viral Inactivation Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Viral Inactivation Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Viral Inactivation Market Size by Country (2022-2027) & (US$ Million)
Table 62. Danaher Company Details
Table 63. Danaher Business Overview
Table 64. Danaher Viral Inactivation Product
Table 65. Danaher Revenue in Viral Inactivation Business (2016-2021) & (US$ Million)
Table 66. Danaher Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Viral Inactivation Product
Table 70. Merck Revenue in Viral Inactivation Business (2016-2021) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Parker Hannifin Company Details
Table 73. Parker Hannifin Business Overview
Table 74. Parker Hannifin Viral Inactivation Product
Table 75. Parker Hannifin Revenue in Viral Inactivation Business (2016-2021) & (US$ Million)
Table 76. Parker Hannifin Recent Development
Table 77. Sartorius Company Details
Table 78. Sartorius Business Overview
Table 79. Sartorius Viral Inactivation Product
Table 80. Sartorius Revenue in Viral Inactivation Business (2016-2021) & (US$ Million)
Table 81. Sartorius Recent Development
Table 82. SGS Company Details
Table 83. SGS Business Overview
Table 84. SGS Viral Inactivation Product
Table 85. SGS Revenue in Viral Inactivation Business (2016-2021) & (US$ Million)
Table 86. SGS Recent Development
Table 87. Charles River Laboratories International Company Details
Table 88. Charles River Laboratories International Business Overview
Table 89. Charles River Laboratories International Viral Inactivation Product
Table 90. Charles River Laboratories International Revenue in Viral Inactivation Business (2016-2021) & (US$ Million)
Table 91. Charles River Laboratories International Recent Development
Table 92. Clean Cells Company Details
Table 93. Clean Cells Business Overview
Table 94. Clean Cells Viral Inactivation Product
Table 95. Clean Cells Revenue in Viral Inactivation Business (2016-2021) & (US$ Million)
Table 96. Clean Cells Recent Development
Table 97. Rad Source Technologies Company Details
Table 98. Rad Source Technologies Business Overview
Table 99. Rad Source Technologies Revenue in Viral Inactivation Business (2016-2021) & (US$ Million)
Table 100. Rad Source Technologies Recent Development
Table 101. Texcell Company Details
Table 102. Texcell Business Overview
Table 103. Texcell Viral Inactivation Product
Table 104. Texcell Revenue in Viral Inactivation Business (2016-2021) & (US$ Million)
Table 105. Texcell Recent Development
Table 106. Viral Inactivated Plasma Systems Company Details
Table 107. Viral Inactivated Plasma Systems Business Overview
Table 108. Viral Inactivated Plasma Systems Viral Inactivation Product
Table 109. Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2016-2021) & (US$ Million)
Table 110. Viral Inactivated Plasma Systems Recent Development
Table 111. Wuxi Pharmatech (Cayman) Company Details
Table 112. Wuxi Pharmatech (Cayman) Business Overview
Table 113. Wuxi Pharmatech (Cayman) Viral Inactivation Product
Table 114. Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2016-2021) & (US$ Million)
Table 115. Wuxi Pharmatech (Cayman) Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Viral Inactivation Market Share by Type: 2020 VS 2027
Figure 2. Kits and Reagents Features
Figure 3. Services Features
Figure 4. Viral Inactivation Systems and Accessories Features
Figure 5. Global Viral Inactivation Market Share by Application: 2020 VS 2027
Figure 6. Blood and Blood Products Case Studies
Figure 7. Cellular and Gene Therapy Products Case Studies
Figure 8. Stem Cell Products Case Studies
Figure 9. Tissue and Tissue Products Case Studies
Figure 10. Vaccines and Therapeutics Case Studies
Figure 11. Viral Inactivation Report Years Considered
Figure 12. Global Viral Inactivation Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Viral Inactivation Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Viral Inactivation Market Share by Regions: 2020 VS 2027
Figure 15. Global Viral Inactivation Market Share by Regions (2022-2027)
Figure 16. Global Viral Inactivation Market Share by Players in 2020
Figure 17. Global Top Viral Inactivation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Inactivation as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Viral Inactivation Revenue in 2020
Figure 19. Global Viral Inactivation Revenue Market Share by Type (2016-2021)
Figure 20. Global Viral Inactivation Revenue Market Share by Type (2022-2027)
Figure 21. North America Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Viral Inactivation Market Share by Type (2016-2027)
Figure 23. North America Viral Inactivation Market Share by Application (2016-2027)
Figure 24. North America Viral Inactivation Market Share by Country (2016-2027)
Figure 25. United States Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Viral Inactivation Market Share by Type (2016-2027)
Figure 29. Europe Viral Inactivation Market Share by Application (2016-2027)
Figure 30. Europe Viral Inactivation Market Share by Country (2016-2027)
Figure 31. Germany Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Viral Inactivation Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Viral Inactivation Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Viral Inactivation Market Share by Region (2016-2027)
Figure 41. China Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Viral Inactivation Market Share by Type (2016-2027)
Figure 49. Latin America Viral Inactivation Market Share by Application (2016-2027)
Figure 50. Latin America Viral Inactivation Market Share by Country (2016-2027)
Figure 51. Mexico Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Viral Inactivation Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Viral Inactivation Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Viral Inactivation Market Share by Country (2016-2027)
Figure 57. Turkey Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Viral Inactivation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Danaher Revenue Growth Rate in Viral Inactivation Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Viral Inactivation Business (2016-2021)
Figure 62. Parker Hannifin Revenue Growth Rate in Viral Inactivation Business (2016-2021)
Figure 63. Sartorius Revenue Growth Rate in Viral Inactivation Business (2016-2021)
Figure 64. SGS Revenue Growth Rate in Viral Inactivation Business (2016-2021)
Figure 65. Charles River Laboratories International Revenue Growth Rate in Viral Inactivation Business (2016-2021)
Figure 66. Clean Cells Revenue Growth Rate in Viral Inactivation Business (2016-2021)
Figure 67. Rad Source Technologies Revenue Growth Rate in Viral Inactivation Business (2016-2021)
Figure 68. Texcell Revenue Growth Rate in Viral Inactivation Business (2016-2021)
Figure 69. Viral Inactivated Plasma Systems Revenue Growth Rate in Viral Inactivation Business (2016-2021)
Figure 70. Wuxi Pharmatech (Cayman) Revenue Growth Rate in Viral Inactivation Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed